Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development and Initial Validation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire (ITP-PAQ), a Disease-Specific Health-Related Quality of Life (HRQoL) Questionnaire.

Susan D. Mathias, MPH, James B. Bussel, MD, James N. George, MD, Robert McMillan, MD, Gary J. Okano, RPh, PhD, Janet L. Nichol, MS

Blood (2006) 108 (11): 1078.

https://doi.org/10.1182/blood.V108.11.1078.1078

Published: 2006

Journal Articles

Safety Profile of AMG 531 in Healthy Volunteers and in Thrombocytopenic Patients with Immune Thromobocytopenic Purpura.

Daniel E. Stepan, MD, Elaine Sergis-Deavenport, RN, MS, CPNP, Reggie Kelly, BS, Jenny Christal, PhD, Chien-Feng Chen, PhD, Janet L. Nichol, MS

Blood (2005) 106 (11): 1240.

https://doi.org/10.1182/blood.V106.11.1240.1240

Published: 2005

Journal Articles

A Novel Thrombopoiesis-Stimulating Agent, AMG 531: Pharmacokinetics and Pharmacodynamics in FcRn Knock-Out and Wild Type Mice.

Yu-Nien Sun, PhD, Rosalin Arends, PhD, Anthony Smithson, Ann Watson, BS, Janet L. Nichol, MS

Blood (2005) 106 (11): 3575.

https://doi.org/10.1182/blood.V106.11.3575.3575

Published: 2005

Journal Articles

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

Adrian Newland, MD, Marie T. Caulier, MD, Martin R. Schipperus, MD, Maria Kappers-Klunne, MD, Bruno R. Varet, Karen Watkins, BA, Chien-Feng Chen, PhD, Janet L. Nichol, MS

Blood (2004) 104 (11): 2058.

https://doi.org/10.1182/blood.V104.11.2058.2058

Published: 2004

Journal Articles

A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

David Kuter, MD, DPhil, James B. Bussel, MD, Louis M. Aledort, MD, James George, MD, Roger M. Lyons, MD, George T. Conklin, MD, Alan E. Lichtin, MD, Jorge Nieva, MD, Reggie Kelly, BA, Chien-Feng Chen, PhD, Janet L. Nichol, MS

Blood (2004) 104 (11): 511.

https://doi.org/10.1182/blood.V104.11.511.511

Published: 2004

NARROW

Development and Initial Validation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire (ITP-PAQ), a Disease-Specific Health-Related Quality of Life (HRQoL) Questionnaire.

Safety Profile of AMG 531 in Healthy Volunteers and in Thrombocytopenic Patients with Immune Thromobocytopenic Purpura.

A Novel Thrombopoiesis-Stimulating Agent, AMG 531: Pharmacokinetics and Pharmacodynamics in FcRn Knock-Out and Wild Type Mice.

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

Development and Initial Validation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire (ITP-PAQ), a Disease-Specific Health-Related Quality of Life (HRQoL) Questionnaire.

Safety Profile of AMG 531 in Healthy Volunteers and in Thrombocytopenic Patients with Immune Thromobocytopenic Purpura.

A Novel Thrombopoiesis-Stimulating Agent, AMG 531: Pharmacokinetics and Pharmacodynamics in FcRn Knock-Out and Wild Type Mice.

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only